Skip to main content
Caplight Logo









RICOVR Healthcare

RICOVR Healthcare

Private
Princeton, New JerseyHealthcare & Life Scienceshttps://ricovr.com/

Last Round

Series A

Sep 13, 2024

Total Funding Raised

$6.92M

Company Overview

RICOVR Healthcare is a healthtech company that has developed a saliva-based biosensor testing device designed for rapid point-of-care testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Compliance

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care diagnosticsdrug testingsaliva drug testworkplace drug screeningbiosensor technologymedical devicerapid diagnostic testmicrofluidic cartridgesworkplace safetyTHC testingPOC testingdrug testing kiton-site testingdrug test device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RICOVR Healthcare Comparables

Compare RICOVR Healthcare with similar companies based on industry and business-model similarity.

RICOVR Healthcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hound Diagnostics
88%
Premier Biotech
83%
Cannabix Technologies Inc
77%

RICOVR Healthcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 13, 2024
GrantJul 24, 2024
GrantJan 23, 2023
Pre SeedApr 19, 2021
GrantSep 15, 2020
Seed
Apr 29, 2020

Key People

Founding team and executive leadership

Piyush Sadana

Co-Founder CFO

Founding Team

RICOVR Healthcare Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2024

    Received funding from National Institute on Drug Abuse and NIH RADx.

  • Apr 19, 2021

    $1.5M round led by Achari Ventures.

RICOVR Healthcare Filings

Explore SEC and related filing metadata, where available.

RICOVR Healthcare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RICOVR Healthcare's valuation, stock price, and market status.

Is RICOVR Healthcare a public or private company?

RICOVR Healthcare is a private company.

What is the current stock price of RICOVR Healthcare?

RICOVR Healthcare is a private company with no public stock price. No recent secondary market data is available.

How much is RICOVR Healthcare worth (valuation)?

Valuation information for RICOVR Healthcare is not publicly available.

Can I buy RICOVR Healthcare stock?

RICOVR Healthcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RICOVR Healthcare's last funding round?

RICOVR Healthcare's most recent funding round was VC Round on September 13, 2024.

Who are the main investors in RICOVR Healthcare?

Key investors in RICOVR Healthcare include Achari Ventures, Yaax Capital, HALLEY Venture Partners LP.

Will RICOVR Healthcare IPO soon?

No public IPO plans have been announced for RICOVR Healthcare.

How can I track RICOVR Healthcare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RICOVR Healthcare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range17
Year Founded2018
Last FundingSep 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?